[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Lexaria Bioscience Corp (LEXX)

Lexaria Bioscience Corp (LEXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Lexaria Bioscience Corp 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 CAN

www.lexariabioscience.com Employees: 7 P: 250-765-6424

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Lexaria Bioscience Corp. provides drug delivery platforms. Its patented DehydraTECH(TM) drug delivery technology changes the way Active Pharmaceutical Ingredients enter the bloodstream, promoting healthier ingestion methods, lower overall dosing and higher effectiveness for lipophilic active molecules. Lexaria Bioscience Corp. is based in Kelowna, Canada.

Key Statistics

Overview:

Market Capitalization, $K 14,922
Enterprise Value, $K 13,122
Shares Outstanding, K 24,787
Float, K 22,707
% Float 91.61%
Short Interest, K 382
Short Float 1.54%
Days to Cover 2.51
Short Volume Ratio 0.62
% of Insider Shareholders 8.39%
% of Institutional Shareholders 13.06%

Financials:

Annual Sales, $ 710 K
Annual Net Income, $ -11,900 K
Last Quarter Sales, $ 20 K
Last Quarter Net Income, $ -1,450 K
EBIT, $ -9,460 K
EBITDA, $ -9,370 K

Growth:

1-Year Return -39.58%
3-Year Return -20.32%
5-Year Return -91.29%
5-Year Revenue Growth 86.84%
5-Year Earnings Growth 56.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.06 on 04/13/26
Next Earnings Date 07/13/26
Earnings Per Share ttm -0.47
EPS Growth vs. Prev Qtr 14.29%
EPS Growth vs. Prev Year 60.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

LEXX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -206.02%
Return-on-Assets % -162.53%
Profit Margin % -1,676.06%
Debt/Equity 0.00
Price/Sales 21.77
Price/Cash Flow N/A
Price/Book 2.49
Book Value/Share 0.25
Interest Coverage -1.74
60-Month Beta 0.37
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.